Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LeukoNorm supportive immunotherapy in IVF/ICSI patients with recurrent implantation failure
2006-000014-20Phase 3Terminated
- Sponsor
- CytoChemia
- Start
- Jan 2006
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Recurrent Implantation Failure (RIF) and female infertility comparing LeukoNorm CytoChemia + IVF/ICSI with Placebo + IVF/ICSI (2 arms). Primary endpoint: Clinical pregnancy rate. Started Jan 2006; status: terminated.
02
Drugs
LeukoNorm CytoChemia
03
Conditions
Recurrent Implantation Failure (RIF)female infertility
Beyond the preview
Go deeper on 2006-000014-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000014-20.